BioCentury | Jun 26, 2019
Distillery Therapeutics

Induction of NFE2L2 activity for Alzheimer's disease

...mark.mattson@nih.gov CONTACT: Dong-Gyu Jo, Sungkyunkwan University, Suwon, South Korea email: jodg@skku.edu Claire Quang National Institutes of Health Sungkyunkwan University GA binding protein transcription factor subunit beta 1 (GABPB1) (NRF2B1) Alzheimer's...
BioCentury | Sep 14, 2018
Company News

Telo, GSK targeting TERT to halt glioblastoma cell immortality

...paper's findings. Telo Therapeutics Inc., San Francisco, Calif. Mark Zipkin GlaxoSmithKline plc Telo Therapeutics Inc. University of California San Francisco GA binding protein transcription factor subunit beta 1 (GABPB1) (NRF2B1) Telomerase...
Items per page:
1 - 2 of 2